Texas Permanent School Fund Dynavax Technologies Corp Transaction History

Texas Permanent School Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$10.73 - $12.58 $175,757 - $206,060	-16,380 Reduced 14.48%	96,748 $1.09 Million
Q1 2024 May 03, 2024	BUY	$11.7 - $14.98 $17,163 - $21,975	1,467 Added 1.31%	113,128 $1.4 Million
Q4 2023 Feb 08, 2024	BUY	$13.09 - $14.98 $29,805 - $34,109	2,277 Added 2.08%	111,661 $1.56 Million
Q3 2023 Nov 09, 2023	BUY	$12.64 - $14.99 $52,721 - $62,523	4,171 Added 3.96%	109,384 $1.62 Million
Q2 2023 Aug 07, 2023	SELL	$9.85 - $13.17 $11,780 - $15,751	-1,196 Reduced 1.12%	105,213 $1.36 Million
Q1 2023 May 01, 2023	BUY	$9.44 - $11.88 $251,472 - $316,471	26,639 Added 33.39%	106,409 $1.04 Million
Q4 2022 Feb 07, 2023	SELL	$10.27 - $13.29 $49,511 - $64,071	-4,821 Reduced 5.7%	79,770 $849,000
Q3 2022 Oct 25, 2022	SELL	$9.93 - $17.44 $3,118 - $5,476	-314 Reduced 0.37%	84,591 $883,000
Q2 2022 Aug 08, 2022	BUY	$7.45 - $12.83 $632,542 - $1.09 Million	84,905 New	84,905 $1.07 Million

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

Stay updated on Texas Permanent School Fund with notifications on news.